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Abstract Nucleotide sequence analysis has indicated that
the A32L gene of orf virus can encode an ATPase (Chan
et al. in Gene 432:44–53, 2009). In this work, we cloned
the A32L gene into a prokaryotic expression vector, and
the recombinant protein was expressed and purified. The
antigenicity of recombinant ATPase was examined by
immunoblotting, and its identity was confirmed by mass
spectrometry. The ATP hydrolysis function of the purified
recombinant protein was examined, and our results showed
that it exhibited the ATPase activity. Similar to other viral
ATPases, the ATPase of orf virus remained active in the
presence of different divalent ions; nevertheless, unlike
other viral ATPases, our recombinant ATPase exhibited
similar enzymatic activity in reaction buffers of different pH.
Orf virus is classified as a member of the genus Para-
poxvirus and has a linear double-stranded DNA genome of
approximately 134–139 kbp. The orf virion is about
260 nm in length and 160 nm in width. The virion shape is
ovoid with a crisscross pattern on its surface. Viral DNA
replication, transcription, and virion assembly occur in the
cytoplasm [5, 6, 9, 14, 16].
Orf virus infection can give rise to contagious ecthyma
in goats, sheep, and other ruminants. The clinical signs of
the disease are proliferative lesions around the muzzle and
lips; occasionally the gums and tongue are affected, which
is frequently found in young lambs. The disease lasts about
3–4 weeks, and affected animals may recover in
1–2 months. The mortality rate is approximately 10% in
lambs and 93% in baby goats [8, 9, 13, 15, 18].
The A32L gene (following the nomenclature of vaccinia
virus), open reading frame 108, is near the right end of the
map of the orf virus genome. The A32L gene is predicted
to encode an ATPase that may be involved in packaging of
viral DNA into virions [2, 10, 11]. In vaccinia virus, the
viral ATPase is a core-associated enzyme [16]. An A32
deletion mutant of vaccinia virus has been shown to reduce
viral DNA packaging [2]. Although the A32L nucleotide
sequence of orf virus is similar to that of the A32 gene of
vaccinia virus [4], the role of the A32L gene in orf viral
DNA packaging has not been studied.
Based on our previous sequence analysis of the A32L
gene [4], we have further investigated the biochemical
function of the recombinant A32L gene in this study.
Cloning, expression, purification and identification of the
A32L gene product were carried out, and the biochemical
results demonstrated that the recombinant protein expres-
sed from the cloned A32L gene displayed ATPase activity.
To our knowledge, this work is the first report of bio-
chemical analysis of orf virus ATPase.
Electronic supplementary material The online version of this
article (doi:10.1007/s00705-010-0754-5) contains supplementary
material, which is available to authorized users.
F.-Y. Lin  H.-C. Wang  M.-L. Wong (&)
Department of Veterinary Medicine,
College of Veterinary Medicine,
National Chung Hsing University,
Taichung, Taiwan
e-mail: mlwong@dragon.nchu.edu.tw
K.-W. Chan
Department of Veterinary Medicine,
National Chiayi University, Chiayi, Taiwan
W.-L. Hsu (&)
Graduate Institute of Microbiology and Public Health,
College of Veterinary Medicine,
National Chung Hsing University,
Taichung, Taiwan
e-mail: wlhsu@dragon.nchu.edu.tw
123
Arch Virol (2010) 155:1701–1705
DOI 10.1007/s00705-010-0754-5
Total DNA was extracted from skin lesions from a goat
infected with orf virus, and subsequently, the targeted
A32L gene of the Taiping strain (GenBank accession
number EU327510) was cloned into the pCRII vector
(Invitrogen) as described previously [3, 4]. For further
cloning of the A32L gene into an expression vector, the
A32L gene was amplified by PCR with one set of primers
(F primer: GGAGATATGGATCCGGATGTCGTGCAG;
R primer: GGCGCTCAGCGGCCGCATTGCCGCCG)
that were designed to incorporate BamHI and NotI
restriction enzyme sites. PCR was conducted following the
manufacturer’s instructions (TOYOBO; Blend-Taq) at a
final concentration of 0.2 mM dNTP, 0.2 lM of each pri-
mer, 2 mM Tris–HCl, 10 mM KCl, and 2 mM MgCl2. The
PCR program was started with an initial denaturation at
94C for 3 min, followed by 30 cycles of denaturation at
94C for 50 s, annealing at 59C for 1 min, and an
extension at 72C for 45 s, and it was ended with a final
extension at 72C for 7 min.
For construction of the expression plasmid, both the
PCR product and the pET32b vector (Novagen) were
digested with BamHI and NotI restriction enzymes at 37C
for 2 h. The subsequent ligation between pET32b and the
insert containing the A32L gene was done using T4 DNA
ligase, and the resulting plasmid is illustrated in Fig. 1a.
Competent cells were then transformed with the ligation
mix and spread onto an ampicillin-selection plate. Six
colonies were selected and grown in 4 mL ampicillin-
containing broth at 37C for 6 h. The identity of plasmids
was examined by BamHI and NotI digestion and automated
DNA sequencing.
For protein expression, BL21 AI bacteria (Invitrogen)
were transformed with the constructed plasmid, and
expression was induced by the addition of isopropyl
b-D-1-thiogalactopyranoside (IPTG) to a final concentra-
tion of 0.8 mM and 0.2% L-arabinose (CALBIOCHEM) at
16C for 24 h. Then, the bacterial pellet was collected,
resuspended in lysis buffer (0.05 M Tris–HCl, 0.5 M NaCl,
10 mM imidazole, pH 7.4), subjected to three cycles of
freezing and thawing, and sonicated on ice for 6 min. The
supernatant containing the native form of the recombinant
protein was recovered by centrifugation for 30 min at 4C
and then purified using the chelating Sepharose Fast Flow
(GE Healthcare) according to the manufacturer’s instruc-
tions with modifications. In brief, the crude bacteria lysate
was mixed with Ni2?-charged Sepharose and rocked at 4C
for 2 h. The matrix was washed several times with 10 ml
wash buffer (0.05 M Tris–HCl, 0.5 M NaCl, 20 mM
imidazole, pH 7.4) to remove non-specifically bound
endogenous histidine-containing proteins, and finally, the
desired recombinant His-tag A32L protein was eluted in
4 mL elution buffer (0.05 M Tris–HCl, 0.5 M NaCl,
400 mM imidazole, pH 7.4).
The purified protein was examined by western blotting.
The primary antibody was mouse anti-HisTag antibody
(AbD Serotec), and the secondary antibody was a goat anti-
mouse antibody conjugated with horseradish peroxidase
(HRP). Detection was performed following the manufac-
turer’s instructions (ECL Chemiluminescence System,
Amersham, GE Healthcare) and visualized using X-ray
films. In addition, the ATPase identity of the recombinant
A32L protein was verified by mass spectrometry analysis
(Mission Biotech, Taipei, Taiwan).
The purified recombinant protein was dialyzed in PBS to
remove urea and imidazole. The concentration of the
recombinant protein was determined by the Bradford
method (Bio-Rad). For functional assays, the protein (1, 2
or 4 lg) was mixed with 10 ll of 39 assay buffer
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Fig. 1 Map of the A32L gene inserted into the pET32b plasmid for
protein expression (a). Purification and immunoblot of the recombi-
nant A32L protein (b, c). The lysate and the purified protein were
separated by SDS-PAGE and stained with Coomassie blue (b).
Western blot with mouse antibody against-His-tag (c). Lane 1
thioredoxin expressed from the pET32b vector as a positive control,
lane 2 purified thioredoxin; lane 3 recombinant A32L protein
expressed in crude bacterial lysate, lane 4 purified recombinant
A32L protein, M prestained protein markers (Bio-Rad). The 50 kDa
A32L protein and thioredoxin (20 kDa) are indicated by arrows
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(150 mM HEPES, pH 7.5, 150 mM NaCl, 15 mM MgCl2)
and 0.15 lCi of radioactive [a-32P]ATP in a total final
volume of 30 ll and incubated at 37C for 30 or 60 min
[20]. Then, 5 ll of each reaction mixture was spotted onto
a polyethyleneimine (PEI) cellulose thin-layer chroma-
tography (TLC) plate (Merck) and developed in a solvent
system (1 M acetic acid and 5 M LiCl). Finally, an auto-
radiogram was obtained by exposing the TLC plate to an
X-ray film.
To express the recombinant ATPase protein, host cells
were transformed with plasmid pET32b-A32L, and
expression was induced by the addition of IPTG and
L-arabinose. The A32L recombinant protein was expressed
and purified (Fig. 1b), and the recombinant protein dis-
played a molecular size of approximately 50 kDa on 10%
SDS-PAGE, as expected. Using a mouse anti-His-tag
antibody, the recombinant protein was examined by wes-
tern blotting, which demonstrated that the recombinant
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Fig. 2 Functional assay of recombinant A32L protein showing its
ATPase activity. a Each reaction contained 1 lg of recombinant
protein and 0.15 lCi of [a-32P]ATP. From lane 2–5, increasing
ATPase activity was observed with increasing reaction time, as
indicated by the appearance of ADP and AMP products. Compared
with the recombinant ATPase, the tag protein, thioredoxin, (lane 6–
9), as the background control, did not show ATPase activity. Lane 1
reaction mixture containing [a-32P]ATP only and no additional
proteins (negative control). b The effect of enzyme concentration on
ATPase activity. These reactions were carried out with different
protein concentrations (1, 2, and 4 lg), and the reaction mixtures
were incubated at 37C for 30 min. The A32L protein demonstrates
increasing ATPase activity that is dose-dependent (lanes 2–4). The
thioredoxin expressed from the empty pET32b vector (lanes 5–7)
served as a background control. Lane 1 reaction buffer including only
[a-32P]ATP as a negative control. c ATPase activity of recombinant
protein in buffers with different pH values. Reactions were conducted
in assay buffers of different pH values (5.5, 6.5, 7.5 and 8.5); 2 lg of
recombinant protein was used for each reaction, and the reaction
mixtures were incubated at 37C for 30 min. The results demon-
strated similar ATPase activities of recombinant protein at different
pH values. d Quantitation of ATPase activity analyzed using the
FLUORCHEM SP computer program. The values are the means of
three independent reactions, and error bars are standard errors of the
means
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protein could react with the antibody (Fig. 1c). The identity
of the purified recombinant protein was confirmed by mass
spectrometry, and partial amino acid sequence data indi-
cated that our recombinant protein was an ATPase (data
not shown).
To determine whether the purified recombinant A32L
protein possessed ATPase activity, the ATPase function of
our recombinant protein was assayed by its ability to
hydrolyze ATP. The reaction products were analyzed by
TLC. As shown in Fig. 2a, ATPase activity could be
observed, with hydrolysis of ATP and production of ADP
and AMP, and this enzymatic activity increased in pro-
portion to the incubation time. In addition, A32L also
showed more ATP hydrolysis with increasing concentra-
tion of the recombinant protein (Fig. 2b). In contrast, the
tag protein thioredoxin produced from the empty vector
pET32b did not display ATPase activity when the incu-
bation time or protein concentration in the reaction were
increased (Fig. 2a, b).
From nucleotide sequences analysis, it is known that the
A32L gene of orf virus is homologous to the A32 gene of
vaccinia virus [4, 11]. However, the in vitro ATPase
function of vaccinia virus A32 gene has not been reported
yet. Our results provide experimental evidence that the
A32L gene of orf virus encodes a functional ATPase in
vitro.
Next, the effect of different pH conditions on enzyme
activity was examined. The results demonstrated that the
recombinant ATPase could hydrolyze ATP in buffer of pH
5.5, 6.5, 7.5 or 8.5 with almost the same activity (Fig. 2c).
It is unusual that an enzyme retains similar activity over
such a wide pH range. In contrast, studies of several other
viral ATPases have shown that their enzyme activity varies
significantly as the pH changes [12, 17, 20].
The effect of metal ions on the ATPase activity of our
protein was also studied. It was found that the recombinant
ATPase had similar enzymatic activity in the presence of
Mg, Ca or Mn ions in the reaction buffer (Supplementary
information).
The nucleotide sequences of the A32L gene of orf virus
(Taiping strain; GenBank accession number EU327510)
and of the A32 of vaccinia virus (Copenhagen strain;
GenBank accession number M35027.1) share about 82%
similarity [4], and the deduced amino acid sequences
contain highly conserved functional motifs of ATPases,
suggesting that they have similar biochemical properties
and a similar biological function in virus DNA packaging.
Deletion analysis of the vaccinia virus A32 gene resulted in
noninfectious, DNA-deficient viral particles [2]. However,
the roles of the A32L gene product in DNA packaging and
morphogenesis of the orf virion remain unknown.
Vaccinia virus can produce at least two other ATPases
that are DNA-dependent. One is encoded by the A18R
gene and has DNA helicase activity [1, 19], and the other,
called NPH-I (nucleoside triphosphate phosphohydrolase-
I), contains a DExH box and plays a role in termination of
transcription [7]. The homologues of A18R-encoded
ATPase and NPH-1 ATPase of vaccinia virus in orf virus
have not been studied yet.
In this work, we successfully cloned and expressed the
A32L gene into a pET32b expression vector, and its ATP-
ase activity was demonstrated. Interestingly, under different
pH conditions, our recombinant ATPase displayed similar
levels of activity. This finding differs from what has been
observed with of other viral ATPases [12, 17, 20].
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